"Renown Institute for Cancer offers patients and their families a nationally-recognized program of treatment, support and care options to maintain the highest quality of life and achieve the best possible outcome from cancer challenges. Clinical expertise and advanced treatment methods allow our dedicated team to develop personalized plans that address the needs, comfort and success of each patient."

During the past decade, Renown Institute for Cancer at Renown Regional Medical Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 12 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Renown Institute for Cancer at Renown Regional Medical Center" #1 sponsor was "Radiation Therapy Oncology Group" with 10 trials, followed by "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "NSABP Foundation Inc" with 2 trials sponsored, "American College of Radiology Imaging Network" with 1 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Renown Institute for Cancer at Renown Regional Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 17 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "Radiation Therapy Oncology Group" with 2 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator and "North Central Cancer Treatment Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Renown Institute for Cancer at Renown Regional Medical Center" are "Lung Cancer" (5 trials), "Head and Neck Cancer" (3 trials), "Prostate Cancer" (3 trials), "Breast Cancer" (2 trials) and "Metastatic Cancer" (2 trials). Many other conditions were trialed in "Renown Institute for Cancer at Renown Regional Medical Center" in a lesser frequency.

Most popular intervention types in "Renown Institute for Cancer at Renown Regional Medical Center" are "Drug" (13 trials), "Radiation" (10 trials), "Other" (4 trials), "Biological" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (4 trials), "cisplatin" (3 trials), "Carboplatin" (2 trials), "Paclitaxel" (2 trials) and "carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Renown Institute for Cancer at Renown Regional Medical Center" are 12 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Renown Institute for Cancer at Renown Regional Medical Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Renown Institute for Cancer at Renown Regional Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Renown Institute for Cancer at Renown Regional Medical Center, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".